Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...
Top drugmakers have spent more than a decade investigating and advancing anti-amyloid Alzheimer's medicines in clinical ...
A new medical review finds "trivial" benefits for amyloid drugs. See why U.S. experts say these findings may not tell the ...
Aug. 1, 2005 — Europe has approved orphan drugs pegylated arginine deiminase for the treatment of hepatocellular carcinoma, soluble yeast beta-1,3/1,6-glucan for the prophylaxis of mucositis due to ...
A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers. Using clinical information from a large, ...
Over the past 15 years, University of Alabama at Birmingham endocrinologist Anath Shalev, M.D., has unraveled a crucial biological pathway that malfunctions in diabetes. Her latest discovery in this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results